Skip to content

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07682597
Enrollment
200
Registered
2026-07-06
Start date
2026-03-01
Completion date
2029-07-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Screening

Brief summary

This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.

Interventions

BEHAVIORALQUILS SBI Intervention

Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.

Sponsors

Timothy Mullett
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Member of a state-based lung cancer screening implementation team in Mississippi or Nevada. * Leadership member of the Mississippi state team or Nevada state team * Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC) * Willing to participate in study-related assessments an implementation activities

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Change in Statewide Capacity Assessment Scores for Lung Cancer Screening Implementation and Sustainability CapacityUp to 3 YearsStatewide capacity will be assessed using the State Team Assessment (STA) and Coalition Assessment (CA) instruments. Higher scores indicate greater capacity to implement an sustain lung cancer screening activities.

Countries

United States

Contacts

CONTACTJoseph Alexander, MD
joseph.alexander@uky.edu8593230892

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026